scPharmaceuticals Inc [NASDAQ: SCPH] traded at a high on Thursday, posting a 0.78 gain after which it closed the day’ session at $2.57.
The results of the trading session contributed to over 249629 shares changing hands. Over the past one week, the price volatility of scPharmaceuticals Inc stands at 10.39% while the volatility over the past one month is 10.67%.
The market cap for SCPH stock reached $129.23 million, with 50.10 million shares outstanding and 34.26 million shares in the current float. Compared to the average trading volume of 459.32K shares, SCPH reached a trading volume of 249629 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about scPharmaceuticals Inc [SCPH]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SCPH shares is $15.17 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SCPH stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Craig Hallum have made an estimate for scPharmaceuticals Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 07, 2023. While these analysts kept the previous recommendation, Cowen raised their target price to Outperform. The new note on the price target was released on December 01, 2022, representing the official price target for scPharmaceuticals Inc stock. Previously, the target price had yet another raise to $14, while Jefferies analysts kept a Buy rating on SCPH stock.
The Average True Range (ATR) for scPharmaceuticals Inc is set at 0.24, with the Price to Sales ratio for SCPH stock in the period of the last 12 months amounting to 3.56. The Price to Book ratio for the last quarter was 9.67, with the Price to Cash per share for the same quarter was set at 1.50.
How has SCPH stock performed recently?
scPharmaceuticals Inc [SCPH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 27.54. With this latest performance, SCPH shares dropped by -15.46% in over the last four-week period, additionally sinking by -39.67% over the last 6 months – not to mention a drop of -44.97% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SCPH stock in for the last two-week period is set at 47.35, with the RSI for the last a single of trading hit 51.74, and the three-weeks RSI is set at 45.18 for scPharmaceuticals Inc [SCPH]. The present Moving Average for the last 50 days of trading for this stock 2.97, while it was recorded at 2.53 for the last single week of trading, and 3.88 for the last 200 days.
scPharmaceuticals Inc [SCPH]: Deeper insight into the fundamentals
scPharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.18 and a Current Ratio set at 7.12.
Insider trade positions for scPharmaceuticals Inc [SCPH]
There are presently around $84.92%, or 95.59%% of SCPH stock, in the hands of institutional investors. The top three institutional holders of SCPH stocks are: ORBIMED ADVISORS LLC with ownership of 5.56 million shares, which is approximately 14.2608%. RUBRIC CAPITAL MANAGEMENT LP, holding 3.52 million shares of the stock with an approximate value of $$15.33 million in SCPH stocks shares; and RUBRIC CAPITAL MANAGEMENT LP, currently with $$15.24 million in SCPH stock with ownership which is approximately 8.9891%.
